Ann Arbor Stage IV Grade 3 Follicular Lymphoma Active Not Recruiting Phase 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0093323 (Ann Arbor Stage IV Grade 3 Follicular Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01145495Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaTreatment